Home

SVF Holdings (UK) LLP

CIK 1716727 · last filed 2022-11-15

SVF Holdings (UK) LLP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider sold $82.5M of ROIVW on Nov 15, 2022. Across all open-market trades the lifetime net is −$80.7M, making them a net seller over the disclosed history. The firm reports its address in London, X0. 29 SEC filings were submitted jointly with SoftBank Vision Fund L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

4

Lifetime Open-Market Net

-$80.73M

Filer Profile

Reported Address
69 GROSVENOR STREET
LONDON, X0 W1K3JP
Phone
(650) 843-5214
State of Incorporation
CA
Related Filers
SoftBank Vision Fund L.P. — 29 joint filings, latest 2023-10-02
SVF Investments (UK) Ltd — 28 joint filings, latest 2023-10-02
SB INVESTMENT ADVISERS (UK) LTD — 5 joint filings, latest 2023-10-02
Roivant Sciences Ltd. — 4 joint filings, latest 2023-10-02
SOFTBANK VISION FUND (AIV M2) L.P. — 1 joint filings, latest 2022-12-19
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Roivant Sciences Ltd. (ROIVW) Delisted 10%+ Owner 95,031,667 $2.75 $261.34M -$82.53M 1 2022-11-15
Urovant Sciences Ltd. (UROV) Delisted 10%+ Owner 22,827,298 $16.24 $370.72M $1.80M 3 2019-06-14

Recent Filings

4 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2022-11-15 Roivant Sciences Ltd. (ROIVW) Delisted Sell (S) −17,375,676 -$82.53M EDGAR
2019-06-14 Urovant Sciences Ltd. (UROV) Delisted Buy (P) +88,044 $709.2K EDGAR
2019-05-29 Urovant Sciences Ltd. (UROV) Delisted Buy (P) +57,940 $441.8K EDGAR
2019-05-20 Urovant Sciences Ltd. (UROV) Delisted Buy (P) +86,428 $651.5K EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.